Skip to content
DraconiticResearch
Search Sources API
203,203 studies31 sourcesUpdated 12 min ago
Peer-reviewedCC BY 4.0Journal of Biological Chemistry

Structural mechanism of TRPC3 inhibition by a potent antagonist

Related

  1. Bivalent CK2 Inhibition as a Potent Strategy Against SARS-CoV-2 and Other Coronaviruses
    D. Salomon Lopez Molina, N. Ahnou, R. Brillet +11
    bioRxivPreprintAll rights reservedFull textMicrobiologybioRxiv
  2. Discovery of potent anti-inflammatory flavonoid-sesquiterpenoid hybrids from Syzygium simile: Structure–activity relationships and nanomolar inhibition of human neutrophil activation
    Yu-Chun Lin, Ho-Cheng Wu, Tsong-Long Hwang +4
    Pharmaceutical BiologyPeer-reviewedCC BY 4.0Full textPlant biologyPMC
  3. Structural Basis of NR2B-Selective Antagonist Recognition by N-Methyl-d-aspartate Receptors
    Laetitia Mony, Lucie Krzaczkowski, Manuel Leonetti +6
    Molecular PharmacologyPeer-reviewedCC BY-NC 4.0Full text53 citedNeuroscienceHAL
  4. Insight into the mechanism of molecular interactions of the NDM metallo-beta-lactamase and cyclic boronate inhibition by molecular docking and molecular dynamics simulations
    Y.-F. Shi
    bioRxivPreprintAll rights reservedFull textBioinformatics & computational biologybioRxiv
  5. Structural and Kinetic Basis for Selective Inhibition of Canine Myeloperoxidase by Staphylococcal Peroxidase Inhibitor (SPIN) Orthologs
    Soheila Fatehi, Timothy J. Herdendorf, Amy Burklund +4
    Journal of Biological ChemistryPeer-reviewedCC BY-NC-ND 4.0ImmunologyCrossref
BibTeX
@article{collingridge2026structural,
  title = {{Structural mechanism of TRPC3 inhibition by a potent antagonist}},
  author = {Jodie Collingridge and Bethan A. Cole and Molly A. Rowlett and John Liddle and Kelly M. Gatfield and Philip C. Biggin and EBE. Becker},
  journal = {Journal of Biological Chemistry},
  year = {2026},
  month = oct,
  doi = {10.1016/j.jbc.2026.113644},
  url = {https://linkinghub.elsevier.com/retrieve/pii/S0021925826025160},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Structural mechanism of TRPC3 inhibition by a potent antagonist
AU  - Jodie Collingridge
AU  - Bethan A. Cole
AU  - Molly A. Rowlett
AU  - John Liddle
AU  - Kelly M. Gatfield
AU  - Philip C. Biggin
AU  - EBE. Becker
PY  - 2026
DA  - 2026/10/01
JO  - Journal of Biological Chemistry
DO  - 10.1016/j.jbc.2026.113644
UR  - https://linkinghub.elsevier.com/retrieve/pii/S0021925826025160
SN  - 0021-9258
ER  -